Adel Maamar

Dr. Adel Maamar

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Radiology
Verified
Journal Article
Closed access
SKStéphane Kremer
Stéphane Kremer
FLFrançois Lersy
François Lersy
JSJérome de Sèze
Jérome de Sèze
JFJean-Christophe Ferré
Jean-Christophe Ferré
AMAdel Maamar
Adel Maamar
FCFrancois Cotton
Francois Cotton
Background Brain MRI parenchymal signal abnormalities have been in association with SARS-CoV-2. Purpose Describe the neuroimaging findings (excluding ischemic infarcts) in patients with severe COVI...

15 October 2019 in JAMA
Verified
Journal Article
Open access
PDF file
ATArnaud W Thille
Arnaud W Thille
GMGrégoire Muller
Grégoire Muller
AGArnaud Gacouin
Arnaud Gacouin
RCRémi Coudroy
Rémi Coudroy
MDMaxens Decavèle
Maxens Decavèle
FNfor the HIGH-WEAN Study Group and the REVA Research Network
for the HIGH-WEAN Study Group and the REVA Research Network
In intensive care units (ICUs), approximately 10% to 15% of patients ready to be separated from a ventilator experience extubation failure leading to reintubation.1 In patients considered at high risk, these rates can even exceed 20%.1,2 Because reintubation is associated with particularly high mortality,3,4 a strategy of oxygenation aimed at avoiding reintubation deserves consideration. Although noninvasive ventilation may prevent postextubation respiratory failure in patients at high risk,5-9 only 2 small-scale randomized clinical trials (RCTs) have shown decreased reintubation rates compared with standard oxygen.5,6 The most recent international clinical practice guidelines recommend the use of noninvasive ventilation to prevent postextubation respiratory failure in patients at high risk of extubation failure.10 However, up until now, no large-scale RCT has demonstrated a significant reduction of reintubation rates with noninvasive ventilation compared with standard oxygen. Thereby, most patients are treated with standard oxygen in clinical practice and only 10% of them receive noninvasive ventilation after extubation in the ICU.2,11

21 January 2019 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
CGChristophe Guitton
Christophe Guitton
SEStephan Ehrmann
Stephan Ehrmann
CVChristelle Volteau
Christelle Volteau
GCGwenhael Colin
Gwenhael Colin
AMAdel Maamar
Adel Maamar
MVMickael Vourc’h
Mickael Vourc’h

1 January 2017 in Annals of Intensive Care
Verified
Journal Article
Open access
PDF file
AGarnaud Gacouin
arnaud Gacouin
AMAdel Maamar
Adel Maamar
PFPierre Fillatre
Pierre Fillatre
ESEmmanuelle Sylvestre
Emmanuelle Sylvestre
MDMargaux Dolan
Margaux Dolan
JTJean Marc Tadié
Jean Marc Tadié
While the psychiatric disorders are conditions frequently encountered in hospitalized patients, there are little or no data regarding the characteristics and short- and long-term outcomes in patients with preexisting psychiatric disorders in ICU. Such assessment may provide the opportunity to determine the respective impact on mortality in the ICU and after ICU discharge with reasons for admission, including modalities of self-harm, of underlying psychiatric disorders and prior psychoactive medications. ICU and 1-year survival analysis performed on a retrospective cohort of patients with preexisting psychiatric disorders admitted from 2000 through 2013 in a 21-bed polyvalent ICU in a university hospital. Among the 1751 patients of the cohort, 1280 (73%) were admitted after deliberate self-harm. Psychiatric diagnoses were: schizophrenia, n = 97 (6%); non-schizophrenia psychotic disorder, n = 237 (13%); depression disorder, n = 1058 (60%), bipolar disorder, n = 172 (10%), and anxiety disorder, n = 187 (11%). ICU mortality rate was significantly lower in patients admitted after self-harm than in patients admitted for other reasons than self-harm [38/1288 patients (3%) vs. 53/463 patients (11%), respectively, p < 0.0001]. Compared with patients admitted for deliberate self-poisoning with psychoactive medications, patients admitted for self-harm by hanging, drowning, jumping from buildings, or corrosive chemicals ingestion had a significantly higher ICU mortality rate. In the ICU, SAPS II score [adjusted odds ratio (OR) 1.061, 95% CI 1.041–1.079, p < 0.0001], use of vasopressors (adjusted OR 7.40, 95% CI 2.94–18.51, p < 0.001), out-of-hospital cardiac arrest (adjusted OR 14.70, 95% CI 3.86–38.51, p < 0.001), and self-harm by hanging, drowning, jumping from buildings, or corrosive chemicals ingestion (adjusted OR 11.49, 95% CI 3.76–35.71, p < 0.001) were independently associated with mortality. After ICU discharge SAPS II score [adjusted hazard ratio (HR) 1.023, 95% CI 1.010–1.036, p < 0.01], age (adjusted HR 1.030, 95% CI 1.016–1.044, p < 0.0001), admission for respiratory failure (adjusted HR 2.23, 95% CI 1.19–4.57, p = 0.01), and shock (adjusted HR 3.72, 95% CI 1.97–6.62, p < 0.001) were independently associated with long-term mortality. Neither psychiatric diagnoses nor psychoactive medications received before admission to the ICU were independently associated with mortality. The study provides data on the short- and long-term outcomes of patients with prepsychiatric disorders admitted to the ICU that may guide decisions when considering ICU admission and discharge in these patients.

15 May 2021 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
FRflorian Reizine
florian Reizine
KPKieran Pinceaux
Kieran Pinceaux
MLMathieu Lederlin
Mathieu Lederlin
BABrice Autier
Brice Autier
HGHélène Guegan
Hélène Guegan
Jean-pierre GangneuxJean-pierre Gangneux
Jean-pierre Gangneux
Invasive pulmonary aspergillosis (IPA) in intensive care unit patients is a major concern. Influenza-associated acute respiratory distress syndrome (ARDS) and severe COVID-19 patients are both at risk of developing invasive fungal diseases. We used the new international definitions of influenza-associated pulmonary aspergillosis (IAPA) and COVID-19-associated pulmonary aspergillosis (CAPA) to compare the demographic, clinical, biological, and radiological aspects of IAPA and CAPA in a monocentric retrospective study. A total of 120 patients were included, 71 with influenza and 49 with COVID-19-associated ARDS. Among them, 27 fulfilled the newly published criteria of IPA: 17/71 IAPA (23.9%) and 10/49 CAPA (20.4%). Kaplan–Meier curves showed significantly higher 90-day mortality for IPA patients overall (p = 0.032), whereas mortality did not differ between CAPA and IAPA patients. Radiological findings showed differences between IAPA and CAPA, with a higher proportion of features suggestive of IPA during IAPA. Lastly, a wide proportion of IPA patients had low plasma voriconazole concentrations with a higher delay to reach concentrations > 2 mg/L in CAPA vs. IAPA patients (p = 0.045). Severe COVID-19 and influenza patients appeared very similar in terms of prevalence of IPA and outcome. The dramatic consequences on the patients’ prognosis emphasize the need for a better awareness in these particular populations.

1 January 2017 in Annals of Intensive Care
Verified
Journal Article
Open access
PDF file
RMRafael Mahieu
Rafael Mahieu
TRThomas Reydel
Thomas Reydel
AMAdel Maamar
Adel Maamar
JTJean-Marc Tadié
Jean-Marc Tadié
AJAngeline Jamet
Angeline Jamet
NLNicolas Lerolle
Nicolas Lerolle
An extended course of tetanus (up to 6 weeks) requiring ICU admission and protracted mechanical ventilation (MV) may have a significant impact on short- and long-term survival. The subject is noteworthy and deserves to be discussed. Twenty-two ICUs in France performed tetanus screenings on patients admitted between January 2000 and December 2014. Retrospective data were collected from hospital databases and through the registers of the town hall of the patients. Seventy patients were included in 15 different ICUs. Sixty-three patients suffered from severe or very severe tetanus according to the Ablett classification. The median age was 80 years [interquartile range 73–84], and 86% of patients were women. Ninety per cent of patients (n = 63) required MV for a median of 36 days [26–46], and 66% required administration of a neuromuscular-blocking agent for 23 days [14–29]. A nosocomial infection occurred in 43 patients (61%). ICU and 1-year mortality rates were 14% (n = 10) and 16% (n = 11), respectively. Forty-five per cent of deaths occurred during the first week. Advanced age, a higher SAPS II, any infection, and the use of vasopressors were significantly associated with a lower number of days alive without ventilator support by day 90. Age was the only factor that significantly differed between deceased and survivors at 1 year (83 [81–85] vs. 79 [73–84] years, respectively; p = 0.03). Sixty-one per cent of survivors suffered no impairment to their functional status. In a high-income country, tetanus mainly occurs in healthy elderly women. Despite prolonged MV and extended ICU length of stay, we observed a low 1-year mortality rate and good long-term functional status.